This is stated on the WHO Twitter page.
“WHO today listed two vaccine options for COVID-19 from AstraZeneca and the University of Oxford for emergency use,” the statement said.
"Today WHO gave emergency use listing to two versions of the Oxford-AstraZeneca # COVID19 vaccine, giving the green light for these vaccines to be rolled out globally through COVAX" - @ DrTedros # VaccinEquity # ACTogetherhttps: //t.co/mbmm1ZAOeM
- World Health Organization (WHO) (@WHO) February 15, 2021
It is emphasized that this decision "provides the green light for the use of these vaccines on a global scale through the COVAX mechanism."
It is clarified that this vaccine is produced by two different factories in India and South Korea.
Although they both manufacture the same drug, each vaccine variant has been tested separately for them, and this is associated with two approvals.
Earlier, the Ministry of Health of Mexico said that the country received the first delivery of the vaccine against the AstraZeneca coronavirus in the amount of 870 thousand doses.